pentobarbital will reduce the level or result of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with potent CYP3A4 inducers may end up in reduced serum concentrations and lack of antimalarial efficacypentobarbital will minimize the level or result of verapamil by influencing hepatic/intestin